Terns Pharmaceuticals, Inc. (TERN)
NASDAQ: TERN · Real-Time Price · USD
5.75
+0.15 (2.75%)
Nov 21, 2024, 1:13 PM EST - Market open
Terns Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 489 | 401 | 504 | 179 | - | - | |
| Market Cap Growth | 129.24% | -20.44% | 182.17% | - | - | - | |
| Enterprise Value | 104 | 135 | 318 | 1 | - | - | |
| Last Close Price | 5.60 | 6.49 | 10.18 | 7.07 | - | - | |
| PS Ratio | - | - | - | 178.64 | - | - | |
| PB Ratio | 1.30 | 1.57 | 1.82 | 1.11 | - | - | |
| P/TBV Ratio | 1.93 | 1.57 | 1.82 | 1.11 | - | - | |
| EV/Sales Ratio | - | - | - | 1.44 | - | - | |
| Debt / Equity Ratio | 0.00 | 0.00 | 0.00 | - | 0.19 | - | |
| Asset Turnover | - | - | - | 0.01 | - | - | |
| Quick Ratio | 32.67 | 22.06 | 33.43 | 24.34 | 3.28 | 3.97 | |
| Current Ratio | 32.99 | 22.39 | 33.68 | 24.48 | 3.98 | 4.49 | |
| Return on Equity (ROE) | -28.28% | -33.89% | -27.60% | -43.83% | -68.73% | -131.24% | |
| Return on Assets (ROA) | -19.23% | -23.08% | -17.04% | -23.94% | -39.83% | -38.94% | |
| Return on Capital (ROIC) | -20.00% | -24.00% | -17.68% | -25.78% | -46.38% | -41.95% | |
| Earnings Yield | -18.52% | -22.49% | -11.97% | -28.08% | - | - | |
| FCF Yield | -15.73% | -16.82% | -9.80% | -23.60% | - | - | |
| Buyback Yield / Dilution | -11.75% | -97.76% | -58.69% | -7862.47% | -55.60% | -145.81% | |
| Total Shareholder Return | -11.75% | -97.76% | -58.69% | -7862.47% | -55.60% | -145.81% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.